Spotlight
Clinical
Conferences
CME/CE
Lynn J. Howie, MD, MA
Articles
A Comparison of FDA and EMA Drug Approval: Implications for Drug Development and Cost of Care
December 15th 2013The development and approval of oncology therapeutics has been facilitated by the cooperation and coordination of regulatory practices between the EMA and the FDA. However, there continue to be important differences between the decisions of the two agencies.
